UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Anti-cancer drugs, ISSN 0959-4973, 06/2014, Volume 25 Update on Taxanes in Cancer Therapy, Issue 5, pp. 488 - 494
P-glycoprotein | P450 cytochrome | Docetaxel | Paclitaxel | Taxane pharmacology | Protein binding | Pharmacology & Pharmacy | Oncology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | Paclitaxel - pharmacology | Taxoids - pharmacology | Administration, Metronomic | Humans | Antineoplastic Agents - therapeutic use | Paclitaxel - pharmacokinetics | Paclitaxel - therapeutic use | Neoplasms - drug therapy | Taxoids - pharmacokinetics | Taxoids - therapeutic use | Maximum Tolerated Dose | Drug Interactions | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Index Medicus
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 10/2003, Volume 2, Issue 10, pp. 971 - 984
Life Sciences & Biomedicine | Oncology | Science & Technology | Chromatin - metabolism | Phosphorylation | Taxoids - pharmacology | Coloring Agents - pharmacology | Annexin A5 - pharmacology | Humans | Epothilones - pharmacology | Multienzyme Complexes - metabolism | Deoxycytidine - pharmacology | Proteasome Endopeptidase Complex | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | Sepharose - pharmacology | Cysteine Endopeptidases - metabolism | Flow Cytometry | Cyclins - metabolism | Time Factors | Antimetabolites, Antineoplastic - pharmacology | Antineoplastic Agents - pharmacology | Hydroxamic Acids - pharmacology | Detergents - pharmacology | Receptor, ErbB-2 - biosynthesis | Cyclin-Dependent Kinase Inhibitor p21 | Antibodies, Monoclonal - pharmacology | Down-Regulation | Enzyme Inhibitors - pharmacology | Tetrazolium Salts - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Blotting, Western | Precipitin Tests | Blotting, Northern | Cell Line, Tumor | Histone Deacetylase Inhibitors | Thiazoles - pharmacology | Antineoplastic Agents, Phytogenic - pharmacology | Deoxycytidine - analogs & derivatives | Microscopy, Fluorescence | Trastuzumab | Apoptosis | Index Medicus
Journal Article
International journal of pharmaceutics, ISSN 0378-5173, 12/2011, Volume 421, Issue 2, pp. 332 - 340
Cancer nanotechnology | PEGylation | Molecular biomaterials | Nanomedicine | Stealth liposomes | Taxotere | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Taxoids - pharmacology | Humans | Vitamin E - analogs & derivatives | Coumarins - chemistry | Polyethylene Glycols - chemistry | Brain Neoplasms | Microscopy, Atomic Force | Antineoplastic Agents - pharmacology | Vitamin E - chemistry | Polyethylene Glycols - pharmacology | Taxoids - chemistry | Cell Survival - drug effects | Microscopy, Electron, Transmission | Antineoplastic Agents - chemistry | Coumarins - pharmacology | Particle Size | Microscopy, Confocal | Liposomes - chemistry | Glioma | Cell Line, Tumor | Absorption - drug effects | Thiazoles - chemistry | Thiazoles - pharmacology | Liposomes - pharmacology | Liposomes - ultrastructure | Vitamin E - pharmacology | Antimitotic agents | Biological products | Antineoplastic agents | Vitamin E | Cancer | Encapsulation | Cell culture | Solvents | Particle size | Brain tumors | Cytotoxicity | Drug delivery | Coatings | Transmission electron microscopy | Polyethylene glycol | Zeta potential | Glioma cells | Liposomes | Index Medicus
Journal Article
European journal of pharmaceutical sciences, ISSN 0928-0987, 03/2012, Volume 45, Issue 4, pp. 492 - 498
Nanoimmunosafety | Micelle | Drug carrier | Complement system | Taxane formulation | Infusion hypersensitivity | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Paclitaxel - pharmacology | Polysorbates - pharmacology | Taxoids - pharmacology | Humans | Antineoplastic Agents - pharmacology | Glycerol - pharmacology | Glycerol - analogs & derivatives | Complement Activation - drug effects | Surface-Active Agents - pharmacology | Drugs | Lectins | Thrombin | Drug delivery systems | Surface active agents | Vehicles | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2341 - 2347
Neoadjuvant chemotherapy | Carboplatin | Homologuous recombinant deficiency | Survival | Triple-negative breast cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Paclitaxel - pharmacology | Prognosis | Taxoids - pharmacology | Follow-Up Studies | Breast - surgery | Humans | Middle Aged | Polyethylene Glycols - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Taxoids - therapeutic use | Carboplatin - therapeutic use | Anthracyclines - pharmacology | Bridged-Ring Compounds - pharmacology | Doxorubicin - analogs & derivatives | Triple Negative Breast Neoplasms - pathology | Mastectomy | Female | Breast - pathology | Polyethylene Glycols - pharmacology | Bridged-Ring Compounds - therapeutic use | Recombinational DNA Repair - genetics | Triple Negative Breast Neoplasms - mortality | Paclitaxel - therapeutic use | Triple Negative Breast Neoplasms - therapy | BRCA1 Protein - genetics | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Triple Negative Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Survival Analysis | Anthracyclines - therapeutic use | Mutation | Carboplatin - pharmacology | BRCA2 Protein - genetics | Doxorubicin - pharmacology | Index Medicus
Journal Article
Cancer treatment reviews, ISSN 0305-7372, 2008, Volume 35, Issue 3, pp. 255 - 261
Hematology, Oncology and Palliative Medicine | 2-Methoxyestradiol | Discodermolide | Microtubule-targeting agent | Epothilone | Halichondrin B | Microtubule | Taxane | Colchicine | Vinca alkaloid | Taccalonolide | Life Sciences & Biomedicine | Oncology | Science & Technology | Colchicine - pharmacology | Taxoids - pharmacology | Tubulin Modulators - pharmacology | Colchicine - therapeutic use | Humans | Epothilones - pharmacology | Epothilones - therapeutic use | Lactones - pharmacology | Drug Delivery Systems | Taxoids - therapeutic use | Neoplasms - genetics | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Microtubules - drug effects | Vinca Alkaloids - pharmacology | Microtubules - ultrastructure | Macrolides - pharmacology | Steroids - pharmacology | Steroids - therapeutic use | Antineoplastic Agents, Phytogenic - therapeutic use | Microtubules - physiology | Clinical Trials as Topic | Vinca Alkaloids - therapeutic use | Cell Division - drug effects | Lactones - therapeutic use | Tubulin Modulators - therapeutic use | Neoplasms - drug therapy | Bridged Bicyclo Compounds, Heterocyclic - pharmacology | Animals | Antineoplastic Agents, Phytogenic - pharmacology | Macrolides - therapeutic use | Neoplasms - pathology | Drug Screening Assays, Antitumor | Development and progression | Care and treatment | Leukemia | Analysis | Cancer | Index Medicus | Microtubule-Targeting Agent | Vinca Alkyloid
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 5/2011, Volume 67, Issue 5, pp. 1157 - 1166
Prostate carcinoma | Medicine & Public Health | Paclitaxel | Cancer Research | Oncology | Ascorbate | Pharmacology/Toxicology | Dehydroascorbate | 5-FU | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | Pharmacology. Drug treatments | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Antineoplastic agents | Male genital diseases | Tumors | Cell Survival - drug effects | Taxoids - pharmacology | Apoptosis - drug effects | Humans | Male | Organoplatinum Compounds - pharmacology | Drug Synergism | Prostatic Neoplasms | Vinblastine - analogs & derivatives | Ascorbic Acid - pharmacology | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Dehydroascorbic Acid - pharmacology | Vinblastine - pharmacology | Cell Cycle - drug effects | Camptothecin - pharmacology | Camptothecin - analogs & derivatives | Epirubicin - pharmacology | Drugs | Antimitotic agents | Care and treatment | Anthracyclines | Cell cycle | Drug therapy | Organic acids | Cancer | Index Medicus | Original
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 11/2011, Volume 103, Issue 22, pp. 1665 - 1675
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Cancer Vaccines - pharmacology | Humans | Male | Antineoplastic Agents - therapeutic use | Bevacizumab | Prostatic Neoplasms - immunology | RANK Ligand - pharmacology | Receptors, Androgen - drug effects | Treatment Failure | Prostatic Neoplasms - drug therapy | Phenylthiohydantoin - pharmacology | Tumor Microenvironment - drug effects | Dasatinib | Antibodies, Monoclonal - pharmacology | Angiogenesis Inhibitors - pharmacology | Clusterin - pharmacology | Pyrimidines - pharmacology | Denosumab | Prostate-Specific Antigen - blood | Orchiectomy | Signal Transduction - drug effects | Anilides - pharmacology | Mice | Receptor Cross-Talk - drug effects | Endothelin-1 - antagonists & inhibitors | Immunotherapy - methods | Taxoids - pharmacology | Ipilimumab | Tissue Extracts - pharmacology | Bone Remodeling - drug effects | Pyrrolidines - pharmacology | Antibodies, Monoclonal, Humanized - pharmacology | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Androstenols - pharmacology | Androstenes | Clinical Trials as Topic | Mice, SCID | Phenylthiohydantoin - analogs & derivatives | Biomarkers, Tumor - blood | Xenograft Model Antitumor Assays | Cancer Vaccines - immunology | Pyrroles - pharmacology | Animals | RANK Ligand - antagonists & inhibitors | Pyridines - pharmacology | Thiazoles - pharmacology | Immune response | Development and progression | Cellular signal transduction | Research | Drug therapy | Health aspects | Prostate cancer | Risk factors | Metastasis | Cancer therapies | Index Medicus | Review
Journal Article
Science (American Association for the Advancement of Science), ISSN 0036-8075, 2/2013, Volume 339, Issue 6119, pp. 587 - 590
Trucks | Taxoids | Molecular structure | Microtubules | REPORTS | Atoms | Ligands | Biochemistry | Molecular mechanisms of action | Epothilones | Crystal structure | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Taxoids - chemistry | Tubulin Modulators - chemistry | Taxoids - pharmacology | Protein Structure, Secondary | Epothilones - chemistry | Tubulin Modulators - pharmacology | Epothilones - pharmacology | Crystallography, X-Ray | Antineoplastic Agents - chemistry | Animals | Bridged-Ring Compounds - chemistry | Macrolides - chemistry | Cattle | Microtubules - drug effects | Chickens | Bridged-Ring Compounds - pharmacology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Tubulin - chemistry | Binding Sites | Antimitotic agents | Care and treatment | Drug interactions